Indication
Pyridoxine deficiency
Pyridoxine deficiency is a nutritional and metabolic disorder characterized by inadequate tissue levels of vitamin B6 and its biologically active coenzyme form, pyridoxal 5'-phosphate. Read more about Pyridoxine deficiency
35 drugs 32 manufacturers
Drugs that treat it
Common Pyridoxine deficiency therapies.
VITAMIN B-6 (pyridoxine HCl (vitamin B6))
VITAMIN B-6 (pyridoxine HCl (vitamin B6))
VITAMIN B-6 (pyridoxine HCl (vitamin B6))
PYRIDOXINE HCL (pyridoxine HCl (vitamin B6))
VITAMIN B-6 (pyridoxine HCl (vitamin B6))
PYRIDOXINE (VITAMIN B6) (pyridoxine HCl (vitamin B6))
PYRIDOXINE HCL (pyridoxine HCl (vitamin B6))
PYRIDOXINE HCL (pyridoxine HCl (vitamin B6))
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPyridoxine deficiency is a nutritional and metabolic disorder characterized by inadequate tissue levels of vitamin B6 and its biologically active coenzyme form, pyridoxal 5'-phosphate.
The condition predominantly affects the neurological, dermatologic, and hematologic systems across various populations, often arising secondary to malabsorption, chronic alcohol use disorder, end-stage renal disease, or the use of pyridoxine-inactivating medications such as isoniazid.
Pathophysiologically, impaired coenzyme activity disrupts amino acid metabolism, heme biosynthesis, and neurotransmitter synthesis—notably gamma-aminobutyric acid.
Clinical manifestations typically include peripheral neuropathy, altered mental status, and intractable seizures, alongside microcytic or sideroblastic anemia, glossitis, cheilosis, and seborrheic dermatitis.
- nih.gov
Pyridoxine deficiency is a nutritional and metabolic disorder characterized by inadequate tissue levels of vitamin B6 and its biologically active coenzyme form, pyridoxal 5'-phosphate The condition predominantly affects the neurological, dermatologic, and hematologic systems across various populations, often arising secondary to malabsorption, chronic alcohol use disorder, end-stage renal disease, or the use of pyridoxine-inactivating medications such as isoniazid
- nih.gov
Pyridoxine deficiency is a nutritional and metabolic disorder characterized by inadequate tissue levels of vitamin B6 and its biologically active coenzyme form, pyridoxal 5'-phosphate
- msdmanuals.com
The condition predominantly affects the neurological, dermatologic, and hematologic systems across various populations, often arising secondary to malabsorption, chronic alcohol use disorder, end-stage renal disease, or the use of pyridoxine-inactivating medications such as isoniazid Pathophysiologically, impaired coenzyme activity disrupts amino acid metabolism, heme biosynthesis, and neurotransmitter synthesis—notably gamma-aminobutyric acid Clinical manifestations typically include peripheral...
- nih.gov
Pathophysiologically, impaired coenzyme activity disrupts amino acid metabolism, heme biosynthesis, and neurotransmitter synthesis—notably gamma-aminobutyric acid Clinical manifestations typically include peripheral neuropathy, altered mental status, and intractable seizures, alongside microcytic or sideroblastic anemia, glossitis, cheilosis, and seborrheic dermatitis
- nih.gov
Pathophysiologically, impaired coenzyme activity disrupts amino acid metabolism, heme biosynthesis, and neurotransmitter synthesis—notably gamma-aminobutyric acid
Personalize your experience
Follow Pyridoxine deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.